Page last updated: 2024-09-03

sc 51089 and n-methyl-3,4-methylenedioxyamphetamine

sc 51089 has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies

Compound Research Comparison

Studies
(sc 51089)
Trials
(sc 51089)
Recent Studies (post-2010)
(sc 51089)
Studies
(n-methyl-3,4-methylenedioxyamphetamine)
Trials
(n-methyl-3,4-methylenedioxyamphetamine)
Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine)
411194,2762111,392

Protein Interaction Comparison

ProteinTaxonomysc 51089 (IC50)n-methyl-3,4-methylenedioxyamphetamine (IC50)
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.9351
Sodium-dependent serotonin transporterHomo sapiens (human)1.1761
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)1.06
Sodium-dependent dopamine transporter Homo sapiens (human)1.7609

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiaia, N; Collins, SA; Gudelsky, GA; Huff, C; Yamamoto, BK1

Other Studies

1 other study(ies) available for sc 51089 and n-methyl-3,4-methylenedioxyamphetamine

ArticleYear
3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling.
    Journal of neurochemistry, 2016, Volume: 136, Issue:5

    Topics: Animals; Central Nervous System Stimulants; Dentate Gyrus; Dinoprostone; Glutamic Acid; Hippocampus; Hydrazines; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Oxazepines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction

2016